Treatment Pathways

Which Treatment Pathway May Be Appropriate?

There is no self-diagnosis tool that can substitute for a qualified clinical evaluation. This page describes — in general terms — the kinds of factors clinicians may evaluate when discussing whether GLP-1 medications, bariatric or metabolic surgery, endoscopic procedures, or a combination of approaches may be appropriate for a given patient.

The summary below reflects considerations discussed in guidance from organizations such as ASMBS, ADA, and AACE. It is not a checklist for self-assessment and is not a substitute for a medical evaluation by a licensed clinician.

Body mass index (BMI)

BMI remains a common starting point in obesity care, though most guidance recognizes its limitations. Society documents generally describe eligibility ranges for bariatric or metabolic surgery starting at lower BMI thresholds when significant obesity-related conditions are present. GLP-1 pharmacotherapy is also discussed across BMI categories, again influenced by comorbidities and other factors.

Medical conditions

The presence and severity of obesity-related conditions — including type 2 diabetes, nonalcoholic fatty liver disease (NAFLD/MASLD), hypertension, obstructive sleep apnea, dyslipidemia, and cardiovascular disease — influences both urgency and pathway selection. Some procedures and medications have specific indications related to these conditions.

Previous treatment attempts

Prior attempts at structured nutrition, physical activity, behavioral therapy, and medications inform what may be reasonable to try next. Documenting what has been tried, for how long, with what results, and how it was tolerated is often part of a metabolic consultation.

Surgical history

Previous abdominal surgery, prior bariatric procedures, and anatomic considerations affect which surgical or endoscopic options are technically feasible. Revisional bariatric surgery is its own category with specialized evaluation requirements.

Patient preferences and goals

Pathway selection is not purely biomedical. Patient preferences regarding indefinite medication use, surgical intervention, frequency of follow-up, work and family obligations, and treatment goals (for example, glycemic control versus weight reduction versus reducing sleep apnea severity) all matter in shared decision-making.

Talking with a clinician

A productive evaluation typically includes a full medical history, physical examination, laboratory testing, and a discussion of values and goals. Multidisciplinary metabolic programs may also include nutrition, behavioral health, and exercise specialists. See Why Patients Seek Coordinated Metabolic Care for more on what an integrated evaluation can include.

Reviewed by

Dr. Ariel Ortiz Lagardere, MD, FACS, FASMBS

Bariatric & Metabolic Surgeon · Founder, Obesity Control Center

Last reviewed: June 2026

Sources

Educational claims on this page are supported by independent guidelines, peer-reviewed evidence, and verifiable accreditation listings. See Sources & Verification and Science & Evidence.

Medical notice. This content is educational only and does not replace professional medical advice. Do not start, stop, or change GLP-1 medication without consulting your physician.